1. Home
  2. LSTA vs HUIZ Comparison

LSTA vs HUIZ Comparison

Compare LSTA & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • HUIZ
  • Stock Information
  • Founded
  • LSTA 1980
  • HUIZ 2006
  • Country
  • LSTA United States
  • HUIZ China
  • Employees
  • LSTA N/A
  • HUIZ N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • HUIZ Specialty Insurers
  • Sector
  • LSTA Health Care
  • HUIZ Finance
  • Exchange
  • LSTA Nasdaq
  • HUIZ Nasdaq
  • Market Cap
  • LSTA 31.2M
  • HUIZ 29.4M
  • IPO Year
  • LSTA N/A
  • HUIZ 2020
  • Fundamental
  • Price
  • LSTA $2.61
  • HUIZ $3.18
  • Analyst Decision
  • LSTA Strong Buy
  • HUIZ
  • Analyst Count
  • LSTA 1
  • HUIZ 0
  • Target Price
  • LSTA $15.00
  • HUIZ N/A
  • AVG Volume (30 Days)
  • LSTA 70.3K
  • HUIZ 14.6K
  • Earning Date
  • LSTA 02-27-2025
  • HUIZ 03-19-2025
  • Dividend Yield
  • LSTA N/A
  • HUIZ N/A
  • EPS Growth
  • LSTA N/A
  • HUIZ N/A
  • EPS
  • LSTA N/A
  • HUIZ 0.29
  • Revenue
  • LSTA N/A
  • HUIZ $170,927,079.00
  • Revenue This Year
  • LSTA N/A
  • HUIZ N/A
  • Revenue Next Year
  • LSTA N/A
  • HUIZ $10.46
  • P/E Ratio
  • LSTA N/A
  • HUIZ $11.16
  • Revenue Growth
  • LSTA N/A
  • HUIZ N/A
  • 52 Week Low
  • LSTA $2.19
  • HUIZ $2.15
  • 52 Week High
  • LSTA $4.20
  • HUIZ $10.58
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 42.17
  • HUIZ 49.57
  • Support Level
  • LSTA $2.45
  • HUIZ $2.94
  • Resistance Level
  • LSTA $2.74
  • HUIZ $3.44
  • Average True Range (ATR)
  • LSTA 0.32
  • HUIZ 0.21
  • MACD
  • LSTA -0.05
  • HUIZ 0.02
  • Stochastic Oscillator
  • LSTA 16.48
  • HUIZ 54.97

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About HUIZ Huize Holding Limited

Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.

Share on Social Networks: